Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

A TFAP2C Gene Signature is Predictive of Outcome in HER2-positive Breast Cancer.

Wu VT, Kiriazov B, Koch KE, Gu VW, Beck AC, Borcherding N, Li T, Addo P, Wehrspan ZJ, Zhang W, Braun TA, Brown BJ, Band V, Band H, Kulak MV, Weigel RJ.

Mol Cancer Res. 2019 Oct 16. pii: molcanres.0359.2019. doi: 10.1158/1541-7786.MCR-19-0359. [Epub ahead of print]

PMID:
31619506
2.

Targeting Histone Chaperone FACT Complex Overcomes 5-Fluorouracil Resistance in Colon Cancer.

Song H, Zeng J, Roychoudhury S, Biswas P, Mohapatra B, Ray S, Dowlatshahi K, Wang J, Band V, Talmon G, Bhakat KK.

Mol Cancer Ther. 2019 Oct 1. pii: molcanther.0600.2019. doi: 10.1158/1535-7163.MCT-19-0600. [Epub ahead of print]

PMID:
31575655
3.

Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection.

Band VI, Hufnagel DA, Jaggavarapu S, Sherman EX, Wozniak JE, Satola SW, Farley MM, Jacob JT, Burd EM, Weiss DS.

Nat Microbiol. 2019 Oct;4(10):1627-1635. doi: 10.1038/s41564-019-0480-z. Epub 2019 Jun 17.

PMID:
31209306
4.

Heteroresistance: A cause of unexplained antibiotic treatment failure?

Band VI, Weiss DS.

PLoS Pathog. 2019 Jun 6;15(6):e1007726. doi: 10.1371/journal.ppat.1007726. eCollection 2019 Jun. No abstract available.

5.

A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance.

Wozniak JE, Band VI, Conley AB, Rishishwar L, Burd EM, Satola SW, Hardy DJ, Tsay R, Farley MM, Jacob JT, Dumyati G, Jordan IK, Weiss DS.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00107-19. doi: 10.1128/AAC.00107-19. Print 2019 May.

6.

Correction: An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance (doi: 10.1242/dev.138164).

Mohapatra B, Zutshi N, An W, Goetz B, Arya P, Bielecki TA, Mushtaq I, Storck MD, Meza JL, Band V, Band H.

Development. 2018 Nov 2;145(21). pii: dev172650. doi: 10.1242/dev.172650. No abstract available.

7.

Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention.

Ali R, Al-Kawaz A, Toss MS, Green AR, Miligy IM, Mesquita KA, Seedhouse C, Mirza S, Band V, Rakha EA, Madhusudan S.

Cancer Res. 2018 Dec 15;78(24):6818-6827. doi: 10.1158/0008-5472.CAN-18-0633. Epub 2018 Oct 8.

PMID:
30297533
8.

3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition.

Wang Y, Mirza S, Wu S, Zeng J, Shi W, Band H, Band V, Duan B.

Oncotarget. 2018 Aug 14;9(63):32191-32203. doi: 10.18632/oncotarget.25891. eCollection 2018 Aug 14.

9.

Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection.

Band VI, Satola SW, Burd EM, Farley MM, Jacob JT, Weiss DS.

MBio. 2018 Mar 6;9(2). pii: e02448-17. doi: 10.1128/mBio.02448-17.

10.

Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.

Luan H, Mohapatra B, Bielecki TA, Mushtaq I, Mirza S, Jennings TA, Clubb RJ, An W, Ahmed D, El-Ansari R, Storck MD, Mishra NK, Guda C, Sheinin YM, Meza JL, Raja S, Rakha EA, Band V, Band H.

Cancer Res. 2018 May 15;78(10):2524-2535. doi: 10.1158/0008-5472.CAN-16-2140. Epub 2018 Mar 6.

11.

Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function.

Iseka FM, Goetz BT, Mushtaq I, An W, Cypher LR, Bielecki TA, Tom EC, Arya P, Bhattacharyya S, Storck MD, Semerad CL, Talmadge JE, Mosley RL, Band V, Band H.

J Immunol. 2018 Jan 15;200(2):483-499. doi: 10.4049/jimmunol.1601793. Epub 2017 Dec 6.

12.

Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway.

Srivastava S, Mohibi S, Mirza S, Band H, Band V.

Cell Cycle. 2017 Aug 18;16(16):1515-1525. doi: 10.1080/15384101.2017.1339846. Epub 2017 Jul 31.

13.

Mammalian ECD Protein Is a Novel Negative Regulator of the PERK Arm of the Unfolded Protein Response.

Olou AA, Sarkar A, Bele A, Gurumurthy CB, Mir RA, Ammons SA, Mirza S, Saleem I, Urano F, Band H, Band V.

Mol Cell Biol. 2017 Aug 28;37(18). pii: e00030-17. doi: 10.1128/MCB.00030-17. Print 2017 Sep 15.

14.

Corrigendum: Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.

Bhattacharyya S, Rainey MA, Arya P, Mohapatra BC, Mushtaq I, Dutta S, George M, Storck MD, McComb RD, Muirhead D, Todd GL, Gould K, Datta K, Waes JG, Band V, Band H.

Sci Rep. 2017 Mar 23;7:42320. doi: 10.1038/srep42320. No abstract available.

15.

An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance.

Mohapatra B, Zutshi N, An W, Goetz B, Arya P, Bielecki TA, Mushtaq I, Storck MD, Meza JL, Band V, Band H.

Development. 2017 Mar 15;144(6):1072-1086. doi: 10.1242/dev.138164. Epub 2017 Jan 18. Erratum in: Development. 2018 Nov 2;145(21):.

16.

Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.

Nadeau SA, An W, Mohapatra BC, Mushtaq I, Bielecki TA, Luan H, Zutshi N, Ahmad G, Storck MD, Sanada M, Ogawa S, Band V, Band H.

J Biol Chem. 2017 Mar 3;292(9):3666-3682. doi: 10.1074/jbc.M116.772723. Epub 2017 Jan 12.

17.

Mutant PIK3CA Induces EMT in a Cell Type Specific Manner.

Bhagirath D, Zhao X, Mirza S, West WW, Band H, Band V.

PLoS One. 2016 Dec 12;11(12):e0167064. doi: 10.1371/journal.pone.0167064. eCollection 2016.

18.

ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.

Griffin NI, Sharma G, Zhao X, Mirza S, Srivastava S, Dave BJ, Aleskandarany M, Rakha E, Mohibi S, Band H, Band V.

Breast Cancer Res. 2016 Nov 16;18(1):113.

19.

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.

Ahmad DA, Negm OH, Alabdullah ML, Mirza S, Hamed MR, Band V, Green AR, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2016 Oct;159(3):457-67. doi: 10.1007/s10549-016-3967-9. Epub 2016 Sep 3.

20.

Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae.

Band VI, Crispell EK, Napier BA, Herrera CM, Tharp GK, Vavikolanu K, Pohl J, Read TD, Bosinger SE, Trent MS, Burd EM, Weiss DS.

Nat Microbiol. 2016 May 9;1(6):16053. doi: 10.1038/nmicrobiol.2016.53.

21.

Corrigendum to CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface [Cell Signalling 2016 Sep.; 28(9): 1325-35].

Cypher LR, Bielecki TA, Huang L, An W, Iseka F, Tom E, Storck MD, Hoppe AD, Band V, Band H.

Cell Signal. 2016 Dec;28(12):1933. doi: 10.1016/j.cellsig.2016.07.018. Epub 2016 Aug 7. No abstract available.

22.

VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease.

An W, Mohapatra BC, Zutshi N, Bielecki TA, Goez BT, Luan H, Iseka F, Mushtaq I, Storck MD, Band V, Band H.

Oncotarget. 2016 Sep 13;7(37):59006-59016. doi: 10.18632/oncotarget.10638.

23.

Acetylation of Mammalian ADA3 Is Required for Its Functional Roles in Histone Acetylation and Cell Proliferation.

Mohibi S, Srivastava S, Bele A, Mirza S, Band H, Band V.

Mol Cell Biol. 2016 Sep 12;36(19):2487-502. doi: 10.1128/MCB.00342-16. Print 2016 Oct 1.

24.

A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.

Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck MD, Meza J, Sheinin Y, Band V, Band H.

Oncotarget. 2016 Aug 9;7(32):51107-51123. doi: 10.18632/oncotarget.9812.

25.

CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface.

Cypher LR, Bielecki TA, Adepegba O, Huang L, An W, Iseka F, Luan H, Tom E, Storck MD, Hoppe AD, Band V, Band H.

Cell Signal. 2016 Sep;28(9):1325-35. doi: 10.1016/j.cellsig.2016.05.013. Epub 2016 May 17. Erratum in: Cell Signal. 2016 Dec;28(12):1933.

26.

Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.

Bhattacharyya S, Rainey MA, Arya P, Mohapatra BC, Mushtaq I, Dutta S, George M, Storck MD, McComb RD, Muirhead D, Todd GL, Gould K, Datta K, Gelineau-van Waes J, Band V, Band H.

Sci Rep. 2016 Feb 17;6:20727. doi: 10.1038/srep20727. Erratum in: Sci Rep. 2017 Mar 23;7:42320.

27.

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition.

Raja SM, Desale SS, Mohapatra B, Luan H, Soni K, Zhang J, Storck MA, Feng D, Bielecki TA, Band V, Cohen SM, Bronich TK, Band H.

Oncotarget. 2016 Mar 1;7(9):10522-35. doi: 10.18632/oncotarget.7231.

28.

Biophysical characterization and modeling of human Ecdysoneless (ECD) protein supports a scaffolding function.

Mir RA, Lovelace J, Schafer NP, Simone PD, Kellezi A, Kolar C, Spagnol G, Sorgen PL, Band H, Band V, Borgstahl GEO.

AIMS Biophys. 2016;3(1):195-208. doi: 10.3934/biophy.2016.1.195. Epub 2016 Mar 9.

29.

A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP Complex Component RUVBL1 Is Required for the Functional Role of ECD in Cell Cycle Progression.

Mir RA, Bele A, Mirza S, Srivastava S, Olou AA, Ammons SA, Kim JH, Gurumurthy CB, Qiu F, Band H, Band V.

Mol Cell Biol. 2015 Dec 28;36(6):886-99. doi: 10.1128/MCB.00594-15.

30.

The endocytic recycling regulatory protein EHD1 Is required for ocular lens development.

Arya P, Rainey MA, Bhattacharyya S, Mohapatra BC, George M, Kuracha MR, Storck MD, Band V, Govindarajan V, Band H.

Dev Biol. 2015 Dec 1;408(1):41-55. doi: 10.1016/j.ydbio.2015.10.005. Epub 2015 Oct 9.

31.

Alteration/Deficiency in Activation 3 (ADA3) Protein, a Cell Cycle Regulator, Associates with the Centromere through CENP-B and Regulates Chromosome Segregation.

Mohibi S, Srivastava S, Wang-France J, Mirza S, Zhao X, Band H, Band V.

J Biol Chem. 2015 Nov 20;290(47):28299-310. doi: 10.1074/jbc.M115.685511. Epub 2015 Oct 1.

32.

Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.

William BM, An W, Feng D, Nadeau S, Mohapatra BC, Storck MA, Band V, Band H.

Hematology. 2016 May;21(4):218-24. doi: 10.1179/1607845415Y.0000000031. Epub 2015 Jul 15.

33.

p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.

Yun J, Espinoza I, Pannuti A, Romero D, Martinez L, Caskey M, Stanculescu A, Bocchetta M, Rizzo P, Band V, Band H, Kim HM, Park SK, Kang KW, Avantaggiati ML, Gomez CR, Golde T, Osborne B, Miele L.

J Cell Physiol. 2015 Dec;230(12):3115-27. doi: 10.1002/jcp.25052.

34.

Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.

Bhagirath D, Zhao X, West WW, Qiu F, Band H, Band V.

Oncotarget. 2015 Apr 20;6(11):9018-30.

35.

Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.

Band VI, Weiss DS.

Antibiotics (Basel). 2015 Mar;4(1):18-41. doi: 10.3390/antibiotics4010018.

36.

Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy.

An W, Nadeau SA, Mohapatra BC, Feng D, Zutshi N, Storck MD, Arya P, Talmadge JE, Meza JL, Band V, Band H.

Oncotarget. 2015 Apr 30;6(12):10498-509.

37.

The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.

Jerjees DA, Negm OH, Alabdullah ML, Mirza S, Alkaabi M, Hameed MR, Abduljabbar R, Muftah A, Nolan CC, Green AR, Tighe PJ, Band V, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2015 Feb;150(1):91-103. doi: 10.1007/s10549-015-3308-4. Epub 2015 Feb 21.

PMID:
25701120
38.

Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.

Desale SS, Raja SM, Kim JO, Mohapatra B, Soni KS, Luan H, Williams SH, Bielecki TA, Feng D, Storck M, Band V, Cohen SM, Band H, Bronich TK.

J Control Release. 2015 Jun 28;208:59-66. doi: 10.1016/j.jconrel.2015.02.001. Epub 2015 Feb 3.

39.

The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells.

Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim JH, Gurumurthy CB, West W, Qiu F, Band H, Band V.

Cell Cycle. 2015;14(7):990-1000. doi: 10.1080/15384101.2015.1006982.

40.

The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells.

Malhotra GK, Zhao X, Edwards E, Kopp JL, Naramura M, Sander M, Band H, Band V.

BMC Dev Biol. 2014 Dec 20;14:47. doi: 10.1186/s12861-014-0047-4.

41.

Experimental validation of predicted subcellular localizations of human proteins.

Chaturvedi NK, Mir RA, Band V, Joshi SS, Guda C.

BMC Res Notes. 2014 Dec 15;7:912. doi: 10.1186/1756-0500-7-912.

42.

Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Chung BM, Tom E, Zutshi N, Bielecki TA, Band V, Band H.

World J Clin Oncol. 2014 Dec 10;5(5):806-23. doi: 10.5306/wjco.v5.i5.806. Review.

43.

Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.

Ahmad G, Mohapatra BC, Schulte NA, Nadeau SA, Luan H, Zutshi N, Tom E, Ortega-Cava C, Tu C, Sanada M, Ogawa S, Toews ML, Band V, Band H.

Int J Biochem Cell Biol. 2014 Dec;57:123-34. doi: 10.1016/j.biocel.2014.10.019. Epub 2014 Oct 23.

44.

A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.

Bailey TA, Luan H, Tom E, Bielecki TA, Mohapatra B, Ahmad G, George M, Kelly DL, Natarajan A, Raja SM, Band V, Band H.

J Biol Chem. 2014 Oct 31;289(44):30443-58. doi: 10.1074/jbc.M114.608992. Epub 2014 Sep 15.

45.

Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme.

Napier BA, Band V, Burd EM, Weiss DS.

Antimicrob Agents Chemother. 2014 Sep;58(9):5594-7. doi: 10.1128/AAC.02432-14. Epub 2014 Jun 30.

46.

Induction of human plasmablasts during infection with antibiotic-resistant nosocomial bacteria.

Band VI, Ibegbu C, Kaur SP, Cagle SM, Trible R, Jones CL, Wang YF, Kraft CS, Ray SM, Wrammert J, Weiss DS.

J Antimicrob Chemother. 2014 Jul;69(7):1830-3. doi: 10.1093/jac/dku047. Epub 2014 Feb 28.

47.

Distinct effects of EGFR ligands on human mammary epithelial cell differentiation.

Mukhopadhyay C, Zhao X, Maroni D, Band V, Naramura M.

PLoS One. 2013 Oct 4;8(10):e75907. doi: 10.1371/journal.pone.0075907. eCollection 2013.

48.

A comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells.

Helikar T, Kochi N, Kowal B, Dimri M, Naramura M, Raja SM, Band V, Band H, Rogers JA.

PLoS One. 2013 Apr 18;8(4):e61757. doi: 10.1371/journal.pone.0061757. Print 2013.

49.

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.

Mirza S, Rakha EA, Alshareeda A, Mohibi S, Zhao X, Katafiasz BJ, Wang J, Gurumurthy CB, Bele A, Ellis IO, Green AR, Band H, Band V.

Breast Cancer Res Treat. 2013 Feb;137(3):721-31. doi: 10.1007/s10549-012-2363-3. Epub 2013 Jan 4.

50.

Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability.

Mirza S, Katafiasz BJ, Kumar R, Wang J, Mohibi S, Jain S, Gurumurthy CB, Pandita TK, Dave BJ, Band H, Band V.

Cell Cycle. 2012 Nov 15;11(22):4266-74. doi: 10.4161/cc.22613. Epub 2012 Oct 24.

Supplemental Content

Support Center